{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:49:27Z","timestamp":1779331767931,"version":"3.51.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Maharaja Ranjit Singh Punjab Technical University, Bathinda","award":["SMG\/05\/2018"],"award-info":[{"award-number":["SMG\/05\/2018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00210-024-03253-x","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T09:02:07Z","timestamp":1720170127000},"page":"10031-10047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Auranofin-loaded PLGA nanoparticles alleviate cognitive deficit induced by streptozotocin in rats model: modulation of oxidative stress, neuroinflammatory markers, and neurotransmitters"],"prefix":"10.1007","volume":"397","author":[{"given":"Shiv Kumar","family":"Kushawaha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahendra Singh","family":"Ashawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6163-9102","authenticated-orcid":false,"given":"Ashish","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"key":"3253_CR1","doi-asserted-by":"crossref","unstructured":"Abolhasani F et al (2023) Exploring the potential of a novel phenoxy ethyl piperidine derivative with cholinesterase inhibitory properties as a treatment for dementia: insights from STZ animal model of dementia. Neurosci Lett 137332. https:\/\/doi.org\/10.1016\/j.neulet.2023.137332","DOI":"10.1016\/j.neulet.2023.137332"},{"issue":"3","key":"3253_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2019.10.009","volume":"55","author":"NS Abutaleb","year":"2020","unstructured":"Abutaleb NS, Seleem MN (2020) Antivirulence activity of auranofin against vancomycin-resistant enterococci: in vitro and in vivo studies. Int J Antimicrob Agents 55(3):105828. https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.10.009","journal-title":"Int J Antimicrob Agents"},{"key":"3253_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","volume":"105","author":"H Aebi","year":"1984","unstructured":"Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121\u2013126","journal-title":"Methods Enzymol"},{"issue":"1","key":"3253_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s42826-020-00049-x","volume":"36","author":"Y Ahn","year":"2020","unstructured":"Ahn Y et al (2020) Synaptic loss and amyloid-beta alterations in the rodent hippocampus induced by streptozotocin injection into the cisterna magna. Laboratory Animal Research 36(1):1\u20136. https:\/\/doi.org\/10.1186\/s42826-020-00049-x","journal-title":"Laboratory Animal Research"},{"key":"3253_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2023.114714","volume":"457","author":"AH Alhowail","year":"2024","unstructured":"Alhowail AH (2024) Pioglitazone ameliorates DOX-induced cognitive impairment by mitigating inflammation, oxidative stress, and apoptosis of hippocampal neurons in rats. Behav Brain Res 457:114714. https:\/\/doi.org\/10.1016\/j.bbr.2023.114714","journal-title":"Behav Brain Res"},{"key":"3253_CR6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.bioactmat.2022.05.030","volume":"17","author":"B Anand","year":"2022","unstructured":"Anand B et al (2022) Significance of native PLGA nanoparticles in the treatment of Alzheimer\u2019s disease pathology. Bioact Mater 17:506\u2013525. https:\/\/doi.org\/10.1016\/j.bioactmat.2022.05.030","journal-title":"Bioact Mater"},{"key":"3253_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/9781681088235121010010","volume-title":"Nanomaterials: evolution and advancement towards therapeutic drug delivery (part I)","author":"N Bajwa","year":"2021","unstructured":"Bajwa N et al (2021a) Scale-up, pre-clinical and clinical status of poly (lactide-co-glycolide) and its copolymers based drug delivery systems. Nanomaterials: evolution and advancement towards therapeutic drug delivery (part I). Bentham Science Publishers, Singapore, pp 246\u2013292"},{"key":"3253_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2174\/9781681087818121010008","volume-title":"Nanomaterials: evolution and advancement towards therapeutic drug delivery (part I)","author":"N Bajwa","year":"2021","unstructured":"Bajwa N et al (2021b) Chronicles of nanomicelles in drug delivery: from benchside to bedside. Nanomaterials: evolution and advancement towards therapeutic drug delivery (part I). Bentham Science Publishers, Singapore, pp 161\u2013210"},{"issue":"7","key":"3253_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1208\/s12249-022-02386-7","volume":"23","author":"N Bajwa","year":"2022","unstructured":"Bajwa N et al (2022) Development of novel solid nanostructured lipid carriers for bioavailability enhancement using a quality by design approach. AAPS PharmSciTech 23(7):253. https:\/\/doi.org\/10.1208\/s12249-022-02386-7","journal-title":"AAPS PharmSciTech"},{"key":"3253_CR10","doi-asserted-by":"publisher","unstructured":"Bajwa N et al (2023) Drug\u2013polymer conjugates: challenges, opportunities, and future prospects in clinical trials. Academic press, pp 389\u2013469. https:\/\/doi.org\/10.1016\/B978-0-323-91663-9.00011-4","DOI":"10.1016\/B978-0-323-91663-9.00011-4"},{"issue":"7\u20138","key":"3253_CR11","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S1386-1425(98)00337-0","volume":"55","author":"E Baran","year":"1999","unstructured":"Baran E, Tobon-Zapata G, Etcheverry S (1999) Infrared and electronic spectra of auranofin. Spectrochim Acta Part A Mol Biomol Spectrosc 55(7\u20138):1569\u20131573. https:\/\/doi.org\/10.1016\/S1386-1425(98)00337-0","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"key":"3253_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2023.106791","volume":"170","author":"DM Beltagy","year":"2024","unstructured":"Beltagy DM et al (2024) The synergistic effect of nanocurcumin and donepezil on Alzheimer\u2019s via PI3K\/AKT\/GSK-3\u03b2 pathway modulating. Prostaglandins Other Lipid Mediat 170:106791. https:\/\/doi.org\/10.1016\/j.prostaglandins.2023.106791","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"6","key":"3253_CR13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJMp1112456","volume":"366","author":"GA Bolan","year":"2012","unstructured":"Bolan GA, Sparling PF, Wasserheit JN (2012) The emerging threat of untreatable gonococcal infection. N Engl J Med 366(6):485. https:\/\/doi.org\/10.1056\/NEJMp1112456","journal-title":"N Engl J Med"},{"issue":"5","key":"3253_CR14","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.biomaterials.2006.09.047","volume":"28","author":"J Cheng","year":"2007","unstructured":"Cheng J et al (2007) Formulation of functionalized PLGA\u2013PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 28(5):869\u2013876. https:\/\/doi.org\/10.1016\/j.biomaterials.2006.09.047","journal-title":"Biomaterials"},{"issue":"1","key":"3253_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40824-019-0166-x","volume":"23","author":"D Chenthamara","year":"2019","unstructured":"Chenthamara D et al (2019) Therapeutic efficacy of nanoparticles and routes of administration. Biomaterials Research 23(1):1\u201329. https:\/\/doi.org\/10.1186\/s40824-019-0166-x","journal-title":"Biomaterials Research"},{"issue":"12","key":"3253_CR16","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/cns.13032","volume":"24","author":"SY Cui","year":"2018","unstructured":"Cui SY et al (2018) Intracerebroventricular streptozotocin-induced Alzheimer\u2019s disease-like sleep disorders in rats: role of the GABAergic system in the parabrachial complex. CNS Neurosci Ther 24(12):1241\u20131252. https:\/\/doi.org\/10.1111\/cns.13032","journal-title":"CNS Neurosci Ther"},{"key":"3253_CR17","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","volume":"5","author":"J Cummings","year":"2019","unstructured":"Cummings J et al (2019) Alzheimer\u2019s disease drug development pipeline: 2019. Alzheimer\u2019s Dementia: Trans Res Clin Interv 5:272\u2013293. https:\/\/doi.org\/10.1016\/j.trci.2019.05.008","journal-title":"Alzheimer's Dementia: Trans Res Clin Interv"},{"issue":"7","key":"3253_CR18","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3390\/pharmaceutics13071042","volume":"13","author":"A Cunha","year":"2021","unstructured":"Cunha A et al (2021) PLGA-based nanoparticles for neuroprotective drug delivery in neurodegenerative diseases. Pharmaceutics 13(7):1042. https:\/\/doi.org\/10.3390\/pharmaceutics13071042","journal-title":"Pharmaceutics"},{"key":"3253_CR19","doi-asserted-by":"publisher","unstructured":"d \u2018Errico P, Meyer-Luehmann M (2020) Mechanisms of pathogenic tau and A\u03b2 protein spreading in Alzheimer\u2019s disease. Front Aging Neurosci 12: 265. https:\/\/doi.org\/10.3389\/fnagi.2020.00265","DOI":"10.3389\/fnagi.2020.00265"},{"issue":"sup2","key":"3253_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/21691401.2018.1457039","volume":"46","author":"A Dadwal","year":"2018","unstructured":"Dadwal A, Baldi A, Narang RK (2018) Nanoparticles as carriers for drug delivery in cancer. Taylor & Francis 46(sup2):295\u2013305. https:\/\/doi.org\/10.1080\/21691401.2018.1457039","journal-title":"Taylor & Francis"},{"key":"3253_CR21","doi-asserted-by":"publisher","unstructured":"Dewangan P et al (2023) Drug delivery: the conceptual perspectives and therapeutic applications. Polymer-Drug Conjugates, Elsevier, London, Acedemic Press, pp 1\u201338. https:\/\/doi.org\/10.1016\/B978-0-323-91663-9.00010-2","DOI":"10.1016\/B978-0-323-91663-9.00010-2"},{"issue":"1","key":"3253_CR22","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1038\/s41598-020-62696-3","volume":"10","author":"A Elkashif","year":"2020","unstructured":"Elkashif A, Seleem MN (2020) Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae. Sci Rep 10(1):5602. https:\/\/doi.org\/10.1038\/s41598-020-62696-3","journal-title":"Sci Rep"},{"issue":"2","key":"3253_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL et al (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7(2):88\u201395. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9","journal-title":"Biochem Pharmacol"},{"key":"3253_CR24","doi-asserted-by":"publisher","unstructured":"Ellman\u00a0GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82(1):70\u201377. https:\/\/doi.org\/10.1016\/0003-9861(59)90090-6","DOI":"10.1016\/0003-9861(59)90090-6"},{"issue":"25","key":"3253_CR25","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMc1512757","volume":"374","author":"H Fifer","year":"2016","unstructured":"Fifer H et al (2016) Failure of dual antimicrobial therapy in treatment of gonorrhea. N Engl J Med 374(25):2504\u20132506. https:\/\/doi.org\/10.1056\/NEJMc1512757","journal-title":"N Engl J Med"},{"issue":"1","key":"3253_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-018-0558-5","volume":"6","author":"AB Ganz","year":"2018","unstructured":"Ganz AB et al (2018) Neuropathology and cognitive performance in self-reported cognitively healthy centenarians. Acta Neuropathol Commun 6(1):1\u201313. https:\/\/doi.org\/10.1186\/s40478-018-0558-5","journal-title":"Acta Neuropathol Commun"},{"key":"3253_CR27","doi-asserted-by":"publisher","unstructured":"Garg Y et al (2023) Systematic designing and optimization of polymeric nanoparticles using central composite design: a novel approach for nose-to-brain delivery of donepezil hydrochloride. J Clust Sci 1\u201313. https:\/\/doi.org\/10.1007\/s10876-023-02528-2","DOI":"10.1007\/s10876-023-02528-2"},{"issue":"8","key":"3253_CR28","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/rheumatology\/36.8.870","volume":"36","author":"A Glenn\u00e5s","year":"1997","unstructured":"Glenn\u00e5s A et al (1997) Auranofin is safe and superior to placebo in elderly-onset rheumatoid arthritis. Br J Rheumatol 36(8):870\u2013877. https:\/\/doi.org\/10.1093\/rheumatology\/36.8.870","journal-title":"Br J Rheumatol"},{"issue":"1","key":"3253_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-020-00714-2","volume":"12","author":"P Gong","year":"2020","unstructured":"Gong P et al (2020) p47phox deficiency improves cognitive impairment and attenuates tau hyperphosphorylation in mouse models of AD. Alzheimer\u2019s Res Ther 12(1):1\u201318. https:\/\/doi.org\/10.1186\/s13195-020-00714-2","journal-title":"Alzheimer's Res Ther"},{"issue":"4","key":"3253_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2174\/1871527321666220413090541","volume":"22","author":"PC Gurram","year":"2023","unstructured":"Gurram PC et al (2023) Dopaminergic signaling as a plausible modulator of astrocytic toll-like receptor 4: a crosstalk between neuroinflammation and cognition. CNS Neurol Disorders-Drug Targets 22(4):539\u2013557. https:\/\/doi.org\/10.2174\/1871527321666220413090541","journal-title":"CNS Neurol Disorders-Drug Targets"},{"issue":"9","key":"3253_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/biom9090441","volume":"9","author":"S Hira","year":"2019","unstructured":"Hira S et al (2019) \u03b2-Carotene: a natural compound improves cognitive impairment and oxidative stress in a mouse model of streptozotocin-induced Alzheimer\u2019s disease. Biomolecules 9(9):441. https:\/\/doi.org\/10.3390\/biom9090441","journal-title":"Biomolecules"},{"key":"3253_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2021.113699","volume":"419","author":"G Jaiswal","year":"2022","unstructured":"Jaiswal G, Kumar P (2022) Neuroprotective role of apocynin against pentylenetetrazole kindling epilepsy and associated comorbidities in mice by suppression of ROS\/RNS. Behav Brain Res 419:113699. https:\/\/doi.org\/10.1016\/j.bbr.2021.113699","journal-title":"Behav Brain Res"},{"key":"3253_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2021.104828","volume":"137","author":"E Kaplan","year":"2021","unstructured":"Kaplan E et al (2021) Feed-forward LPQNet based automatic Alzheimer\u2019s disease detection model. Comput Biol Med 137:104828. https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104828","journal-title":"Comput Biol Med"},{"key":"3253_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.msec.2018.03.030","volume":"89","author":"A Kaur","year":"2018","unstructured":"Kaur A et al (2018) Self-assembled nanomicelles of amphiphilic clotrimazole glycyl-glycine analogue augmented drug delivery, apoptosis and restrained melanoma tumour progression. Mater Sci Eng, C 89:75\u201386. https:\/\/doi.org\/10.1016\/j.msec.2018.03.030","journal-title":"Mater Sci Eng, C"},{"issue":"3","key":"3253_CR35","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1254\/jphs.09330fp","volume":"113","author":"NH Kim","year":"2010","unstructured":"Kim NH et al (2010) Auranofin, a gold (I)-containing antirheumatic compound, activates Keap1\/Nrf2 signaling via Rac1\/iNOS signal and mitogen-activated protein kinase activation. J Pharmacol Sci 113(3):246\u2013254. https:\/\/doi.org\/10.1254\/jphs.09330fp","journal-title":"J Pharmacol Sci"},{"key":"3253_CR36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","volume":"4","author":"JW Kinney","year":"2018","unstructured":"Kinney JW et al (2018) Inflammation as a central mechanism in Alzheimer\u2019s disease. Alzheimer\u2019s Dementia: Trans Res Clin Interv 4:575\u2013590. https:\/\/doi.org\/10.1016\/j.trci.2018.06.014","journal-title":"Alzheimer's Dementia: Trans Res Clin Interv"},{"key":"3253_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-020-00234-1","volume":"7","author":"D Knopman","year":"2021","unstructured":"Knopman D et al (2021) Tendinopathy. Nat Rev Dis Primers 7:1\u201321","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"3253_CR38","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0003-9861(78)90479-4","volume":"186","author":"Y Kono","year":"1978","unstructured":"Kono Y (1978) Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186(1):189\u2013195. https:\/\/doi.org\/10.1016\/0003-9861(78)90479-4","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"3253_CR39","doi-asserted-by":"publisher","first-page":"94","DOI":"10.2174\/2211738506666180604101920","volume":"6","author":"L Kumar","year":"2018","unstructured":"Kumar L et al (2018) Exploring therapeutic potential of nanocarrier systems against breast cancer. Pharm Nanotechnol 6(2):94\u2013110. https:\/\/doi.org\/10.2174\/2211738506666180604101920","journal-title":"Pharm Nanotechnol"},{"key":"3253_CR40","doi-asserted-by":"publisher","unstructured":"Kushawaha SK et al (2024a) Aurothioglucose encapsulated nanoparticles fostered neuroprotection in streptozotocin-induced Alzheimer\u2019s disease. Brain Res 148906. https:\/\/doi.org\/10.1016\/j.brainres.2024.148906","DOI":"10.1016\/j.brainres.2024.148906"},{"key":"3253_CR41","doi-asserted-by":"publisher","unstructured":"Kushawaha SK et al (2024b) Neuroprotective effect of aurothioglucose-loaded PLGA nanoparticles in an aluminum chloride-induced rat model of Alzheimer\u2019s disease. Res J Pharm Tech. 17(2):756\u2013762. https:\/\/doi.org\/10.52711\/0974-360X.2024.00118","DOI":"10.52711\/0974-360X.2024.00118"},{"issue":"1","key":"3253_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA et al (2018) Alzheimer\u2019s disease. Eur J Neurol 25(1):59\u201370. https:\/\/doi.org\/10.1111\/ene.13439","journal-title":"Eur J Neurol"},{"issue":"22","key":"3253_CR43","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.lfs.2013.04.005","volume":"92","author":"J Madeira","year":"2013","unstructured":"Madeira J et al (2013) Novel protective properties of auranofin: inhibition of human astrocyte cytotoxic secretions and direct neuroprotection. Life Sci 92(22):1072\u20131080. https:\/\/doi.org\/10.1016\/j.lfs.2013.04.005","journal-title":"Life Sci"},{"issue":"1\u20132","key":"3253_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jneuroim.2014.08.615","volume":"276","author":"JM Madeira","year":"2014","unstructured":"Madeira JM et al (2014) Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst. J Neuroimmunol 276(1\u20132):71\u201379. https:\/\/doi.org\/10.1016\/j.jneuroim.2014.08.615","journal-title":"J Neuroimmunol"},{"issue":"3","key":"3253_CR45","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4103\/1673-5374.153686","volume":"10","author":"JM Madeira","year":"2015","unstructured":"Madeira JM et al (2015) A new look at auranofin, dextromethorphan and rosiglitazone for reduction of glia-mediated inflammation in neurodegenerative diseases. Neural Regen Res 10(3):391. https:\/\/doi.org\/10.4103\/1673-5374.153686","journal-title":"Neural Regen Res"},{"issue":"8","key":"3253_CR46","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1002\/jps.21216","volume":"97","author":"Y Meissner","year":"2008","unstructured":"Meissner Y, Lamprecht A (2008) Alternative drug delivery approaches for the therapy of inflammatory bowel disease. J Pharm Sci 97(8):2878\u20132891. https:\/\/doi.org\/10.1002\/jps.21216","journal-title":"J Pharm Sci"},{"issue":"6","key":"3253_CR47","doi-asserted-by":"publisher","first-page":"729","DOI":"10.2174\/1567201811666140709112040","volume":"11","author":"N Mishra","year":"2014","unstructured":"Mishra N et al (2014) Surface modified nanoparticulate carrier constructs for oral mucosal vaccine delivery. Curr Drug Deliv 11(6):729\u2013743. https:\/\/doi.org\/10.2174\/1567201811666140709112040","journal-title":"Curr Drug Deliv"},{"key":"3253_CR48","doi-asserted-by":"publisher","unstructured":"Naderi S et al (2018) The effects of six weeks high intensity interval training on amyloid beta1\u201342 peptide in hippocampus of rat model of Alzheimer\u2019s disease induced with STZ. J Clin Res Paramedical Sci 7(2). https:\/\/doi.org\/10.5812\/jcrps.86866","DOI":"10.5812\/jcrps.86866"},{"issue":"2","key":"3253_CR49","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.leukres.2010.05.011","volume":"35","author":"A Nakaya","year":"2011","unstructured":"Nakaya A et al (2011) The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-\u03baB activity. Leuk Res 35(2):243\u2013249. https:\/\/doi.org\/10.1016\/j.leukres.2010.05.011","journal-title":"Leuk Res"},{"issue":"1","key":"3253_CR50","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"E Nichols","year":"2019","unstructured":"Nichols E, Szoeke CE (2019) Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(1):88\u2013106. https:\/\/doi.org\/10.1016\/S1474-4422(18)30403-4","journal-title":"Lancet Neurol"},{"issue":"2","key":"3253_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jchromb.2005.01.008","volume":"818","author":"BA Patel","year":"2005","unstructured":"Patel BA et al (2005) Simple and rapid determination of serotonin and catecholamines in biological tissue using high-performance liquid chromatography with electrochemical detection. J Chromatogr B 818(2):269\u2013276. https:\/\/doi.org\/10.1016\/j.jchromb.2005.01.008","journal-title":"J Chromatogr B"},{"issue":"8","key":"3253_CR52","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/antiox9080647","volume":"9","author":"A Picca","year":"2020","unstructured":"Picca A et al (2020) Mitochondrial dysfunction, oxidative stress, and neuroinflammation: intertwined roads to neurodegeneration. Antioxidants 9(8):647. https:\/\/doi.org\/10.3390\/antiox9080647","journal-title":"Antioxidants"},{"issue":"3","key":"3253_CR53","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12640-016-9684-7","volume":"31","author":"KG Ravelli","year":"2017","unstructured":"Ravelli KG et al (2017) Intracerebroventricular streptozotocin as a model of Alzheimer\u2019s disease: neurochemical and behavioral characterization in mice. Neurotox Res 31(3):327\u2013333. https:\/\/doi.org\/10.1007\/s12640-016-9684-7","journal-title":"Neurotox Res"},{"issue":"1","key":"3253_CR54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5530\/ijpi.2020.1.5","volume":"10","author":"A Rimpi","year":"2020","unstructured":"Rimpi A, Rahul D (2020) Chebulinic acid negated the development of streptozotocin-induced experimental dementia in rats. Int J Pharmaceutical Investig 10(1):24\u201331. https:\/\/doi.org\/10.5530\/ijpi.2020.1.5","journal-title":"Int J Pharmaceutical Investig"},{"issue":"1","key":"3253_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-018-3720-7","volume":"18","author":"M Sagbakken","year":"2018","unstructured":"Sagbakken M et al (2018) Dementia and immigrant groups: a qualitative study of challenges related to identifying, assessing, and diagnosing dementia. BMC Health Serv Res 18(1):1\u201314. https:\/\/doi.org\/10.1186\/s12913-018-3720-7","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"3253_CR56","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12951-018-0356-z","volume":"16","author":"E S\u00e1nchez-L\u00f3pez","year":"2018","unstructured":"S\u00e1nchez-L\u00f3pez E et al (2018) Memantine loaded PLGA PEGylated nanoparticles for Alzheimer\u2019s disease: In vitro and in vivo characterization. J Nanobiotechnol 16(1):32. https:\/\/doi.org\/10.1186\/s12951-018-0356-z","journal-title":"J Nanobiotechnol"},{"issue":"4","key":"3253_CR57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tim.2013.12.007","volume":"22","author":"TF Sch\u00e4berle","year":"2014","unstructured":"Sch\u00e4berle TF, Hack IM (2014) Overcoming the current deadlock in antibiotic research. Trends Microbiol 22(4):165\u2013167. https:\/\/doi.org\/10.1016\/j.tim.2013.12.007","journal-title":"Trends Microbiol"},{"key":"3253_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mehy.2017.12.015","volume":"111","author":"KA Schiel","year":"2018","unstructured":"Schiel KA (2018) A new etiologic model for Alzheimers disease. Med Hypotheses 111:27\u201335. https:\/\/doi.org\/10.1016\/j.mehy.2017.12.015","journal-title":"Med Hypotheses"},{"key":"3253_CR59","doi-asserted-by":"publisher","unstructured":"Sharma A, Baldi A (2018) Nanostructured lipid carriers: a review. J Dev Drugs7(1) 1000191. https:\/\/doi.org\/10.4172\/2329-6631.1000191","DOI":"10.4172\/2329-6631.1000191"},{"key":"3253_CR60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fcimb.2017.00004.eCollection","volume":"7","author":"S Thangamani","year":"2017","unstructured":"Thangamani S et al (2017) (2017) Repurposing approach identifies auranofin with broad spectrum antifungal activity that targets Mia40-Erv1 pathway. Front Cell Infect Microbiol 7:4. https:\/\/doi.org\/10.3389\/fcimb.2017.00004.eCollection","journal-title":"Front Cell Infect Microbiol"},{"key":"3253_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2020.147022","volume":"1746","author":"J Up\u012bte","year":"2020","unstructured":"Up\u012bte J et al (2020) Subchronic administration of auranofin reduced amyloid-\u03b2 plaque pathology in a transgenic APPNL-GF\/NL-GF mouse model. Brain Res 1746:147022. https:\/\/doi.org\/10.1016\/j.brainres.2020.147022","journal-title":"Brain Res"},{"issue":"5","key":"3253_CR62","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3390\/antiox10050632","volume":"10","author":"SB Wall","year":"2021","unstructured":"Wall SB et al (2021) Auranofin-mediated NRF2 induction attenuates interleukin 1 beta expression in alveolar macrophages. Antioxidants 10(5):632. https:\/\/doi.org\/10.3390\/antiox10050632","journal-title":"Antioxidants"},{"issue":"6","key":"3253_CR63","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/0002-9343(83)90481-3","volume":"75","author":"DT Walz","year":"1983","unstructured":"Walz DT et al (1983) Biologic actions and pharmacokinetic studies of auranofin. Am J Med 75(6):90\u2013108. https:\/\/doi.org\/10.1016\/0002-9343(83)90481-3","journal-title":"Am J Med"},{"key":"3253_CR64","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.physbeh.2018.03.016","volume":"191","author":"D Wang","year":"2018","unstructured":"Wang D et al (2018) Effects of paeoniflorin on neurobehavior, oxidative stress, brain insulin signaling, and synaptic alterations in intracerebroventricular streptozotocin-induced cognitive impairment in mice. Physiol Behav 191:12\u201320. https:\/\/doi.org\/10.1016\/j.physbeh.2018.03.016","journal-title":"Physiol Behav"},{"issue":"10","key":"3253_CR65","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00210-019-01672-9","volume":"392","author":"DP Wang","year":"2019","unstructured":"Wang DP et al (2019) Andrographolide enhances hippocampal BDNF signaling and suppresses neuronal apoptosis, astroglial activation, neuroinflammation, and spatial memory deficits in a rat model of chronic cerebral hypoperfusion. Naunyn Schmiedebergs Arch Pharmacol 392(10):1277\u20131284. https:\/\/doi.org\/10.1007\/s00210-019-01672-9","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"3253_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22319","volume":"33","author":"J Wei","year":"2019","unstructured":"Wei J et al (2019) Protective effect of daidzein against streptozotocin-induced Alzheimer\u2019s disease via improving cognitive dysfunction and oxidative stress in rat model. J Biochem Mol Toxicol 33(6):e22319. https:\/\/doi.org\/10.1002\/jbt.22319","journal-title":"J Biochem Mol Toxicol"},{"issue":"3","key":"3253_CR67","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1042\/bj0990667","volume":"99","author":"E Wills","year":"1966","unstructured":"Wills E (1966) Mechanisms of lipid peroxide formation in animal tissues. Biochemical J 99(3):667. https:\/\/doi.org\/10.1042\/bj0990667","journal-title":"Biochemical J"},{"issue":"2","key":"3253_CR68","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s11064-017-2426-2","volume":"43","author":"ZP Xu","year":"2018","unstructured":"Xu ZP et al (2018) Adiponectin attenuates streptozotocin-induced tau hyperphosphorylation and cognitive deficits by rescuing PI3K\/Akt\/GSK-3\u03b2 pathway. Neurochem Res 43(2):316\u2013323. https:\/\/doi.org\/10.1007\/s11064-017-2426-2","journal-title":"Neurochem Res"},{"key":"3253_CR69","doi-asserted-by":"publisher","unstructured":"Yahaya M et al (2020) Possible epigenetic role of vitexin in regulating neuroinflammation in Alzheimer\u2019s disease. J Immunol Res 1\u20137. https:\/\/doi.org\/10.1155\/2020\/9469210","DOI":"10.1155\/2020\/9469210"},{"issue":"6","key":"3253_CR70","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/jnc.15155","volume":"158","author":"T Yuliani","year":"2021","unstructured":"Yuliani T et al (2021) Central cholinergic function and metabolic changes in streptozotocin-induced rat brain injury. J Neurochem 158(6):1307\u20131319. https:\/\/doi.org\/10.1111\/jnc.15155","journal-title":"J Neurochem"},{"issue":"4","key":"3253_CR71","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3390\/pharmaceutics13040500","volume":"13","author":"K Zhi","year":"2021","unstructured":"Zhi K et al (2021) PLGA nanoparticle-based formulations to cross the blood\u2013brain barrier for drug delivery: From R&D to cGMP. Pharmaceutics 13(4):500. https:\/\/doi.org\/10.3390\/pharmaceutics13040500","journal-title":"Pharmaceutics"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03253-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-024-03253-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-024-03253-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T07:07:39Z","timestamp":1732172859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-024-03253-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":71,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["3253"],"URL":"https:\/\/doi.org\/10.1007\/s00210-024-03253-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,5]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocol received approval from the Institutional Animal Ethics Committee (IAEC) under approval number CPCSEA\/LIPH\/2019\/10. All experimental procedures were conducted according to the guidelines stipulated by CCSEA.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}